SAHPRA Annual Performance Plan 2022 – 2023

This Annual Performance Plan for the 2022/23 financial year that has been developed by SAHPRA, represents the planned actions of the Board of SAHPRA to ensure that through their considered and responsible actions, they can, together with the staff at the Authority, assure and guide the Authority to grow into maturity; and reach its full potential to provide for the monitoring, evaluation, regulation, investigation, inspection, registration and control of medicines, scheduled substances, clinical trials, medical devices, radiation emitting devices and radioactive nuclides and related matters in the public interest.

2022 Jun